Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: A study of 151 Malaysian children

Journal of Tropical Pediatrics

Volumn 46, Issue 2, 2000, Pages 73-78

  Ng, Sze May ^a,c   Ariffin, W A ^a   Lin, H P ^a   Chan, L L ^a   Chin, Y M ^b  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^c ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CD33 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BLAST CELL; BONE MARROW; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; DEMOGRAPHY; DISEASE CLASSIFICATION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INCIDENCE; INFANT; LEUKEMIA CELL; LEUKOCYTE COUNT; LIVER SIZE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDIASTINUM; MORPHOLOGY; NEWBORN; ONSET AGE; PROGNOSIS; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SPLEEN SIZE; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0034011075     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/46.2.73     Document Type: Article

References (17)

1. Hoffbrand AV, Pettit JE (eds) Essential Haematology. Blackwell Science Ltd, London, 1995.
2. Uckun FM, Sather HN, Gaynon PS, et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group Study. Blood 1997; 90: 28-35.
3. Kurec AS, Belair P, Stefanu C, Barrett DM, Dubowy RL, Davey FR. Significance of aberrant immunophenotypes in childhood acute lymphoblastic leukemia. Cancer 1991; 67: 3081-86.
4. Wiersma SR, Ortega J, Sobel E, Weinberg KI. Clinical importance of myeloid antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 1991; 324: 800-8.
5. Pui CH, Raimondi SC, Head DR, et al. Characterization of childhood acute lymphoblastic leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 1991; 78: 1327-37.
6. Pui CH, Behm FG, Singh B, et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75: 198-202.
7. Cortes JE, Kantarjian HM, Freireich EJ. Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393-409.
8. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusion of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-33.
9. Crist W, Carroll A, Schuster J, et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group Study. Blood 1990; 76: 489-94.
10. Reiter A, Schrappe M, Ludwig WD, et al. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 1992; 80: 2471-78.
11. Pui CH, Behm FG, Crist WM. Clinical and biological relevance of immunological marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343-62.
12. + acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 1989; 73: 1000-15.
13. Crist W, Boyett J, Jackson J, et al. Prognostic importance of B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 1989; 74: 1252-59.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1970; 58: 457-63.
15. Drexler HG, Ludwig LD. Incidence and clinical relevance of myeloid-antigen positive acute lymphoblastic leukemia. Recent Results Cancer Res 1993; 131: 53-9.
16. Cantu Rajnoldi, Putti G, Saitta M, et al. Coexpression of myeloid antigens in childhood acute lymphoblastic leukemia: Relationship with stage of differentiation and clinical significance. Br J Haematol 1991; 79: 40-3.
17. Mirro J, Zipf TF, Pui CH, et al. Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115-23.